Correlation Between Precision BioSciences and COSCIENS Biopharma
Can any of the company-specific risk be diversified away by investing in both Precision BioSciences and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precision BioSciences and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precision BioSciences and COSCIENS Biopharma, you can compare the effects of market volatilities on Precision BioSciences and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precision BioSciences with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precision BioSciences and COSCIENS Biopharma.
Diversification Opportunities for Precision BioSciences and COSCIENS Biopharma
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Precision and COSCIENS is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Precision BioSciences and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and Precision BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precision BioSciences are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of Precision BioSciences i.e., Precision BioSciences and COSCIENS Biopharma go up and down completely randomly.
Pair Corralation between Precision BioSciences and COSCIENS Biopharma
Given the investment horizon of 90 days Precision BioSciences is expected to generate 0.99 times more return on investment than COSCIENS Biopharma. However, Precision BioSciences is 1.01 times less risky than COSCIENS Biopharma. It trades about -0.19 of its potential returns per unit of risk. COSCIENS Biopharma is currently generating about -0.26 per unit of risk. If you would invest 829.00 in Precision BioSciences on September 4, 2024 and sell it today you would lose (142.00) from holding Precision BioSciences or give up 17.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Precision BioSciences vs. COSCIENS Biopharma
Performance |
| Timeline |
| Precision BioSciences |
| COSCIENS Biopharma |
Precision BioSciences and COSCIENS Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Precision BioSciences and COSCIENS Biopharma
The main advantage of trading using opposite Precision BioSciences and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precision BioSciences position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.| Precision BioSciences vs. Candel Therapeutics | Precision BioSciences vs. Cingulate Warrants | Precision BioSciences vs. Unicycive Therapeutics | Precision BioSciences vs. Cardio Diagnostics Holdings |
| COSCIENS Biopharma vs. Candel Therapeutics | COSCIENS Biopharma vs. Cingulate Warrants | COSCIENS Biopharma vs. Unicycive Therapeutics | COSCIENS Biopharma vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |